Quantum Biopharma (QNTM) Change in Cash (2019 - 2026)

Quantum Biopharma has reported Change in Cash for 6 years, with the latest figure at $2.4 million in Q1 2026.

• Quarterly Change in Cash rose 198.34% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $823595.0 (up 112.72% YoY) and the FY2025 annual result came in at -$4.1 million, down 226.3% from the prior year.
• Change in Cash improved to $2.4 million in Q1 2026 per QNTM's latest filing, from $1.5 million in the prior quarter.
• Over five years, Change in Cash peaked at $2.9 million in Q4 2024 and troughed at -$6.7 million in Q1 2022.
• A 4-year average of -$706436.8 and a median of -$619023.5 in 2024 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2025 and 2026: Change in Cash slumped 464.13% in 2025, then surged 198.34% in 2026.
• Over 4 years, Change in Cash stood at -$6.7 million in 2022, then surged by 143.01% to $2.9 million in 2024, then sank by 49.25% to $1.5 million in 2025, then soared by 66.95% to $2.4 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $2.4 million, $1.5 million, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.